Clinigen Appoints Greg Skalicky as Chief Executive Officer July 20, 2026 Clinigen, the global pharmaceutical services company dedicated to accelerating access to critical medicines worldwide, today announced the appointment of Greg Skalicky as Group Chief Executive Officer, effective 20 July 2026. Greg succeeds Dr Varun Sethi, who has served as Acting CEO since September 2025. Skalicky brings more than 30 years of leadership experience, with a [...]
IFF Announces Agreement to Sell Its Portfolio of Botanical Extracts, Vitamins & Minerals and Food Enhancement Activities to SuanNutra, a Portfolio Company of Carbyne Equity Partners. July 20, 2026 IFF (NYSE: IFF) — a global leader in flavors, fragrances, and health and biosciences — today announced that it has entered into an agreement with SuanNutra, a Carbyne Equity Partners portfolio company and global provider of science-backed branded and functional ingredients, to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities, [...]
New CultureLab Findings Show Culturally Relevant Brands Worth Nearly Three Times More July 20, 2026 As CMOs get less for every media dollar they spend and as brand investment in creators grows, new research reveals what the world's most valuable brands are doing differently
Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older July 20, 2026 The EMA application is supported by data from the paediatric clinical programme for lebrikizumab, including the pivotal Phase III ADorable-1 study and the ADorable-2 long-term extension study. Atopic dermatitis affects a significant number of children and adolescents and often peaks in childhood – with around 60% of cases appearing within the first year of life1. As atopic dermatitis often begins early in life and can have a lasting impact on patients and their families, effective disease control is increasingly recognised as an important opportunity to reduce long-term disease burden and support healthier life trajectories2.
Agilent Increases Its Investment in HALO X-ray Technologies July 20, 2026 Validation of HALO’s Advanced Security Screening Technology Agilent Technologies, Inc. has led a multimillion dollar investment round in which other existing Blue Chip investors UK Innovation Science Seed Fund (UKI2S) and the Midland Engine Investment Fund (MEIF) also participated. The investment enables HALO to complete regulatory approval of its advanced security screening technology ahead of production and scaling up its commercial activities.
Eaton Opens European Aerospace Additive Manufacturing Center to Expand Production and Strengthen Regional Supply Chain Resilience July 20, 2026 Specialized center delivers production-ready capabilities closer to European aerospace commercial, aftermarket and defense customers Eaton chooses U.K. for its third global additive manufacturing site and second dedicated to the aerospace industry
GRIDSERVE Reports 45% YoY Growth, as UK’s Most-Used Charging Network Proves the Commercial Case for EV Infrastructure at Scale June 19, 2026 GRIDSERVE's national charging network generated £64 million in revenue in 2025, with utilisation increasing across the network The business also reached positive EBITDA for the first time, delivering group EBITDA of £3 million and EBITDA of £26 million on its charging network Milestone reached under new CEO Daniel Kunkel, who joined in March 2025, bringing renewed strategic focus to the core charging business More than three million charging sessions were completed in 2025, driven by growing demand for reliable, convenient charging and GRIDSERVE’s award-winning customer experience
Lone Star Funds Completes Sale of Xella to Holcim June 19, 2026 Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund X, L.P. has completed the sale of Xella Group (“Xella”), a leading provider of walling solutions, to Holcim, the leading partner for sustainable construction. Xella is a provider of efficient and sustainable walling solutions for the entire house shell. Through its [...]
First Trust Global Portfolios Management Limited Announces Distributions for certain sub-funds of First Trust Global Funds ICAV June 18, 2026 First Trust Global Portfolios Management Limited (“FTGPM”) announces the declaration of the distributions for the following sub-funds of First Trust Global Funds ICAV, ISIN Fund Name Frequency Dividend per Share IE00BWTNMB87 First Trust US Large Cap Core AlphaDEX® UCITS ETF Class B Quarterly $0.1637 (USD) IE00BWTNM966 First Trust Germany AlphaDEX® UCITS ETF Class A Quarterly [...]
Janus Henderson Announces Receipt of Required Regulatory Approvals and Client Consents Following Resounding Shareholder Approval of the Trian and General Catalyst Take-Private Transaction June 18, 2026 Anticipates June 30, 2026 Closing Date
